1
Trial of Topical C-82 in Systemic Sclerosis – A Phase I/II Biomarker and Safety Trial
Condition(s):Systemic SclerodermaLast Updated:August 17, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.